Keyword Analysis & Research: eslicarbazepine


Keyword Analysis

Keyword CPC PCC Volume Score Length of keyword
eslicarbazepine0.270.586226715

Keyword Research: People who searched eslicarbazepine also searched

Keyword CPC PCC Volume Score
eslicarbazepine1.450.3497648
eslicarbazepine acetate1.50.777882
eslicarbazepine level0.460.681924
eslicarbazepine spc1.260.2624049
eslicarbazepine bnf1.880.3496790
eslicarbazepine vs carbamazepine1.970.1159452
eslicarbazepine lab test0.230.3318671
eslicarbazepine 400 mg1.690.7813834
eslicarbazepine brand name1.730.9866053
eslicarbazepine vs oxcarbazepine1.610.7635895
eslicarbazepine side effects0.840.3146794
eslicarbazepine zebinix1.690.8915445
eslicarbazepine to carbamazepine conversion1.780.9350886
eslicarbazepine acetate synthesis1.110.2754994
eslicarbazepine blood test10.8873039

Search Results related to eslicarbazepine on Search Engine

  • Sunovion - Wikipedia

    wikipedia.org

    https://en.wikipedia.org/wiki/Sunovion

    Sunovion Pharmaceuticals Inc. (former NASDAQ: SEPR), known until October 12, 2010 as Sepracor, Inc. prior to its acquisition by Sumitomo Dainippon Pharma of Japan, is a pharmaceutical company founded in 1984 by Timothy J. Barberich, Steve Matson, and Bob Bratzler. It was originally located in Princeton, New Jersey and then re-located to Marlborough, …

    DA: 9 PA: 4 MOZ Rank: 73

  • Levonorgestrel | Interactions | BNF content published by NICE

    nice.org.uk

    https://bnf.nice.org.uk/interaction/levonorgestrel-2.html

    Eslicarbazepine. Eslicarbazepine is predicted to decrease the efficacy of levonorgestrel. For FSRH guidance, see Contraceptives, interactions. Severity of interaction: Severe Evidence for interaction: Theoretical. Fosaprepitant.

    DA: 50 PA: 92 MOZ Rank: 28

  • Use of antiepileptic drugs in hepatic and renal disease

    nih.gov

    https://pubmed.ncbi.nlm.nih.gov/24365310/

    Drugs eliminated by a combination of renal excretion and biotransformation include levetiracetam, lacosamide, zonisamide, primidone, phenobarbital, ezogabine/retigabine, oxcarbazepine, eslicarbazepine, ethosuximide, and felbamate. Drugs in the latter group can be used cautiously in patients with either renal or liver failure.

    DA: 2 PA: 76 MOZ Rank: 33

  • Therapeutic Drug Monitoring of Antiepileptic Drugs in …

    nih.gov

    https://pubmed.ncbi.nlm.nih.gov/29957667/

    TDM provides a pragmatic approach to epilepsy care, in that bespoke dose adjustments are undertaken based on drug concentrations so as to optimize clinical outcome. For the older first-generation AEDs (carbamazepine, ethosuximide, phenobarbital, phenytoin, primidone, and valproic acid), much data ha …

    DA: 8 PA: 66 MOZ Rank: 44

  • Tricyclic - Wikipedia

    wikipedia.org

    https://en.wikipedia.org/wiki/Tricyclic

    History. Promethazine and other first generation antihistamines with a tricyclic structure were discovered in the 1940s.; Chlorpromazine, derived from promethazine originally as a sedative, was found to have neuroleptic properties in the early 1950s, and was the first typical antipsychotic.; Imipramine, originally investigated as an antipsychotic, was discovered in the …

    DA: 26 PA: 31 MOZ Rank: 91


  • Desogestrel | Interactions | BNF content published by NICE

    nice.org.uk

    https://bnf.nice.org.uk/interaction/desogestrel-2.html

    Eslicarbazepine is predicted to decrease the efficacy of desogestrel. For FSRH guidance, see Contraceptives, interactions. Severity of interaction: Severe Evidence for interaction: Theoretical. Fosaprepitant. Fosaprepitant is predicted to decrease the efficacy of desogestrel.

    DA: 11 PA: 13 MOZ Rank: 2

  • Reactions Weekly | Home - Springer

    springer.com

    https://www.springer.com/journal/40278

    Reactions Weekly is the unique one-stop-shop for all your adverse drug reaction needs, bringing you up-to-the minute summaries of the world's adverse drug reaction news and published adverse drug reaction case reports.Reactions Weekly provides a weekly round-up of adverse drug reaction news including labelling changes, drug withdrawals due to safety issues, adverse …

    DA: 31 PA: 57 MOZ Rank: 79

  • Partial Seizure Treatment | Oxtellar XR® (oxcarbazepine)

    oxtellarxr.com

    https://www.oxtellarxr.com/

    Do not take Oxtellar XR if you are allergic to oxcarbazepine, or any of the other ingredients in Oxtellar XR, or to eslicarbazepine acetate. Oxtellar XR can cause serious side effects, including a low level of sodium in your blood. Symptoms of low blood sodium include nausea, tiredness, lack of energy, headache, confusion, and more frequent or more severe seizures.

    DA: 70 PA: 99 MOZ Rank: 5

  • Ubrelvy (ubrogepant) dosing, indications, interactions, adverse …

    medscape.com

    https://reference.medscape.com/drug/ubrelvy-ubrogepant-1000348

    eslicarbazepine acetate. eslicarbazepine acetate will decrease the level or effect of ubrogepant by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Modify Therapy/Monitor Closely. Dose adjustment is recommended with concomitant use of ubrogepant and moderate and weak CYP3A4 inducers. (see Dosage Modifications) estrogens conjugated synthetic

    DA: 65 PA: 36 MOZ Rank: 3

  • Seizure Medications: 34 Drugs & Expert Picks for Epilepsy

    healthline.com

    https://www.healthline.com/health/epilepsy/medications-list

    Apr 09, 2021 · Eslicarbazepine (Aptiom) is used to treat focal seizures, including focal to bilateral tonic-clonic seizures. It’s thought to work by blocking sodium …

    DA: 24 PA: 31 MOZ Rank: 81